Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pfizer Inc. (PFE) had Revenue of $18.28B for the most recently reported fiscal quarter, ending 2023-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2023-03-31

Income Statement Financials
Revenue	$18.28B
Net Income	$5.54B
Cost of Goods Sold	$4.89B
Gross Profit	$13.40B
Operating Expenses	$11.94B
Operating Income	$6.34B
Non-Operating Income/Expense	$-70.00M
Pre-Tax Income	$6.27B
Normalized Pre-Tax Income	$6.27B
Income after Taxes	$5.55B
Income from Continuous Operations	$5.55B
Consolidated Net Income/Loss	$5.56B
Normalized Income after Taxes	$5.55B
EBIT	$6.34B
EBITDA	$7.83B
Weighted-Average Shares Outstanding (Basic)	5.63B
Weighted-Average Shares Outstanding (Diluted)	5.73B
Earnings per Share (EPS) (Basic)	$0.98
Earnings per Share (EPS) (Diluted)	$0.97
Balance Sheet Financials
Current Assets	$50.08B
Property, Plant, and Equipment	$17.05B
Long-Term Assets	$145.54B
Total Assets	$195.62B
Current Liabilities	$36.56B
Long-Term Debt	$31.70B
Long-Term Liabilities	$57.82B
Total Liabilities	$94.38B
Common Equity	$101.24B
Tangible Shareholders Equity	$7.76B
Shareholders Equity	$101.24B
Common Shares Outstanding	5.64B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.21B
Cash Flow from Investing Activities	$3.31B
Cash Flow from Financial Activities	$-2.77B
Beginning Cash	$468.00M
End Cash	$2.22B
Increase/Decrease in Cash	$1.75B
Stock-Based Compensation	$105.00M
Common Stock Dividends Paid	$-2.30B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.24
Debt to Equity Ratio	0.35
Gross Margin	73.27%
Operating Margin	34.68%
EBIT Margin	34.68%
EBITDA Margin	--
Pre-Tax Profit Margin	34.30%
Profit Margin	30.32%
Free Cash Flow	$73.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.51
Receiveable Turnover	1.49
Days Sales in Receivables	60.58
Return on Equity	5.49%
Return on Tangible Equity	71.60%
Return on Assets	2.84%
Return on Investments	4.18%
Book Value Per Share	$17.93
Free Cash Flow per Share	$0.01
Operating Cash Flow per Share	$0.21

Data from Zacks Investment Research, Inc.